Blood-Based Detection of BRAF V600E in Gliomas and Brain Tumor Metastasis
Liquid biopsy provides a minimally invasive platform for the detection of tumor-derived information, including hotspot mutations, such as BRAF V600E. In this study, we provide evidence of the technical development of a ddPCR assay for the detection of BRAF V600E mutations in the plasma of patients with glioma or brain metastasis. In a small patient cohort (n = 9, n = 5 BRAF V600E, n = 4 BRAF WT, n = 4 healthy control), we were able to detect the BRAF V600E mutation in the plasma of 4/5 patients with BRAF V600E-tissue confirmed mutant tumors, and none of the BRAF WT tumors. We also provide evidence in two metastatic patients with longitudinal monitoring, where the plasma-based BRAF V600E mutation correlated with clinical disease status. This proof of principle study demonstrates the potential of this assay to serve as an adjunctive tool for the detection, monitoring, and molecular characterization of BRAF mutant gliomas and brain metastasis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Cancers - 13(2021), 6 vom: 11. März |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kang, Keiko M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Brain tumor |
|---|
| Anmerkungen: |
Date Revised 07.05.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/cancers13061227 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323551971 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323551971 | ||
| 003 | DE-627 | ||
| 005 | 20231225184427.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers13061227 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1078.xml |
| 035 | |a (DE-627)NLM323551971 | ||
| 035 | |a (NLM)33799709 | ||
| 035 | |a (PII)1227 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kang, Keiko M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Blood-Based Detection of BRAF V600E in Gliomas and Brain Tumor Metastasis |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 07.05.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Liquid biopsy provides a minimally invasive platform for the detection of tumor-derived information, including hotspot mutations, such as BRAF V600E. In this study, we provide evidence of the technical development of a ddPCR assay for the detection of BRAF V600E mutations in the plasma of patients with glioma or brain metastasis. In a small patient cohort (n = 9, n = 5 BRAF V600E, n = 4 BRAF WT, n = 4 healthy control), we were able to detect the BRAF V600E mutation in the plasma of 4/5 patients with BRAF V600E-tissue confirmed mutant tumors, and none of the BRAF WT tumors. We also provide evidence in two metastatic patients with longitudinal monitoring, where the plasma-based BRAF V600E mutation correlated with clinical disease status. This proof of principle study demonstrates the potential of this assay to serve as an adjunctive tool for the detection, monitoring, and molecular characterization of BRAF mutant gliomas and brain metastasis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a brain tumor | |
| 650 | 4 | |a brain tumor metastasis | |
| 650 | 4 | |a cfDNA (cell free DNA) | |
| 650 | 4 | |a extracellular vesicles | |
| 650 | 4 | |a glioma | |
| 650 | 4 | |a liquid biopsy | |
| 650 | 4 | |a melanoma | |
| 700 | 1 | |a Muralidharan, Koushik |e verfasserin |4 aut | |
| 700 | 1 | |a Yekula, Anudeep |e verfasserin |4 aut | |
| 700 | 1 | |a Small, Julia L |e verfasserin |4 aut | |
| 700 | 1 | |a Rosh, Zachary S |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Pamela S |e verfasserin |4 aut | |
| 700 | 1 | |a Carter, Bob S |e verfasserin |4 aut | |
| 700 | 1 | |a Balaj, Leonora |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d 2009 |g 13(2021), 6 vom: 11. März |w (DE-627)NLM198667213 |x 2072-6694 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g number:6 |g day:11 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/cancers13061227 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2021 |e 6 |b 11 |c 03 | ||